| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Bellini Roberto serves as a Director at IKT. Across recent SEC filings that breaks down to 1 buy and 0 sells. Those positions are worth an estimated $3.6M at current prices.
The biggest single holding is IKT (~$3.6M) as Director. Net of sales, the recent Form 4 record there shows accumulation of 1,460,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 21, 2024 | IKT Inhibikase Therapeutics, Inc. | Director | Buy | 1,460,000 | $1.37 | $2,000,200.00 | New | +26.6% | -28.8% |